HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Turner-Gomes, S. O. Articles by Rabinovitch, M. Search for Related Content PubMed PubMed Citation Articles by Turner-Gomes, S. O. Articles by Rabinovitch, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 87-97, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease

SO Turner-Gomes, M Andrew, J Coles, GA Trusler, WG Williams and M Rabinovitch
Department of Cardiology, Hospital for Sick Children, Hamilton, Ontario, Canada.

In patients with congenital heart disease two poorly understood postoperative complications are pulmonary hypertensive crises after repair of large atrioventricular or ventricular septal defects and right atrial and pulmonary thrombi after the Fontan operation. In this study we assessed whether cardiopulmonary bypass in these patients is associated with the release of agents that might induce platelet aggregation and vasoconstriction, such as biologically active von Willebrand factor and platelet-activating factor. In addition, we measured levels of anticoagulants such as antithrombin III and proteins C and S. Three groups of patients with congenital heart disease undergoing cardiopulmonary bypass were monitored through the perioperative period for secundum atrial septal defects, large atrioventricular or ventricular septal defects, and tricuspid atresia or univentricular heart (Fontan candidates). Control values were obtained from age-matched patients; patients requiring major noncardiac operations and those with cardiac disease not requiring cardiopulmonary bypass were also studied. After cardiopulmonary bypass in all three groups biologic activity of von Willebrand factor increased markedly in the immediate and early postoperative periods compared with preoperative values, whereas antithrombin III values were decreased. Platelet-activating factor was detected in only two patients with congenital heart disease, both in the early postoperative period. In contrast, patients who did not have cardiopulmonary bypass did not show these abnormalities. All measured parameters normalized at late follow- up (6 to 18 months after operation). Although cardiopulmonary bypass in these patients resulted in increased von Willebrand factor activity and decreased antithrombin III, changes that may predispose the patient to platelet aggregation and thrombus formation, absolute values in individual patients alone were not predictive of pulmonary hypertensive crises or detectable thrombi. This suggests that these hematologic abnormalities may contribute to but are not by themselves a cause of morbidity in the early postoperative period. Moreover, the increased von Willebrand factor biologic activity seen postoperatively in patients with congenital heart disease suggests that use of synthetic vasopressin may be ineffective and potentially detrimental.

This article has been cited by other articles:

				M. Ranucci, A. Ditta, A. Boncilli, M. Cotza, G. Carboni, S. Brozzi, C. Bonifazi, and A. Tiezzi Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass Perfusion, January 1, 2004; 19(1): 47 - 52. [Abstract] [PDF]

				L. Lindberg, C. Forsell, P. Jogi, and A.-K. Olsson Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery Br. J. Anaesth., June 1, 2003; 90(6): 728 - 732. [Abstract] [Full Text] [PDF]

				A. Ghai, L. Harris, D. A. Harrison, G. D. Webb, and S. C. Siu Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation J. Am. Coll. Cardiol., February 1, 2001; 37(2): 585 - 592. [Abstract] [Full Text] [PDF]

				H J Brinks, P W Weerwind, S Bogdan, H Verbruggen, and M H. Brouwer Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Perfusion, January 1, 2001; 16(1): 3 - 12. [Abstract] [PDF]

				G. M. Tsang, S. Allen, D. Pagano, C. Wong, T. R Graham, and R. S Bonser von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 385 - 391. [Abstract] [Full Text] [PDF]

				P. J. Chai, J. A. Williamson, A. J. Lodge, C. W. Daggett, J. E. Scarborough, J. N. Meliones, I. M. Cheifetz, J. J. Jaggers, and R. M. Ungerleider Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass Ann. Thorac. Surg., March 1, 1999; 67(3): 731 - 735. [Abstract] [Full Text] [PDF]

				M. Beghetti, P. E. Silkoff, M. Caramori, H. M. Holtby, A. S. Slutsky, and I. Adatia Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury Ann. Thorac. Surg., August 1, 1998; 66(2): 532 - 534. [Abstract] [Full Text] [PDF]

				J. Petaja, U. Lundstrom, H. Sairanen, E. Marttinen, and J. H. Griffin CENTRAL VENOUS THROMBOSIS AFTER CARDIAC OPERATIONS IN CHILDREN J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 883 - 889. [Abstract] [Full Text]

				J. Petaja, K. Peltola, H. Sairanen, M. Leijala, R. Kekomaki, E. Vahtera, and M. A. Siimes FIBRINOLYSIS, ANTITHROMBIN III, AND PROTEIN C IN NEONATES DURING CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 665 - 671. [Abstract] [Full Text]

				A. Serraf, P. Herve, C. Labat, G.-M. Mazmanian, V. de Montpreville, C. Planche, and C. Brink Endothelial Dysfunction in Venous Pulmonary Hypertension in the Neonatal Piglet Ann. Thorac. Surg., May 1, 1995; 59(5): 1155 - 1161. [Abstract] [Full Text]

				S. O. Turner-Gomes, L. Mitchell, W. G. Williams, and M. Andrew Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 562 - 568. [Abstract] [Full Text]

				J. B. Gupta, M. Prasad, J. Kalra, and K. Prasad Platelet-Activating-Factor-Induced Changes in Cardiovascular Function and Oxyradical Status of Myocardium in Presence of the PAF Antagonist CV-6209 Angiology, January 1, 1994; 45(1): 25 - 36. [Abstract] [PDF]